DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 202179
The generic ingredient in PREDNISOLONE SODIUM PHOSPHATE is prednisolone sodium phosphate. There are eighty-six drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
Summary for 202179
Tradename: | PREDNISOLONE SODIUM PHOSPHATE |
Applicant: | Mylan Pharms Inc |
Ingredient: | prednisolone sodium phosphate |
Patents: | 0 |
Therapeutic Class: | Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) Inflammatory Bowel Disease Agents Ophthalmic Agents |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 202179
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 202179
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate | TABLET, ORALLY DISINTEGRATING;ORAL | 202179 | ANDA | Mylan Pharmaceuticals Inc. | 0378-4710 | N | 0378-4710-22 |
PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate | TABLET, ORALLY DISINTEGRATING;ORAL | 202179 | ANDA | Mylan Pharmaceuticals Inc. | 0378-4715 | N | 0378-4715-22 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Apr 10, 2013 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | EQ 15MG BASE | ||||
Approval Date: | Apr 10, 2013 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | EQ 30MG BASE | ||||
Approval Date: | Apr 10, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription